Skip to content
ApprovedFDA approvedStrong evidence

Nortriptyline

Prescription antidepressant for depression; outside its approval it is also prescribed for nerve pain and migraine prevention.

AntidepressantTricyclic antidepressantAntidepressantMoodNorepinephrineSerotoninAcetylcholinenoo.affects.histamine
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAntidepressant · Mood
Primary targetNorepinephrine transporter (NET) reuptake inhibition
Targets5 receptor targets
Half-lifeAbout 18 to 44 hours (roughly one day)
OnsetMood benefit typically develops over 2 to 4 weeks; sleep and pain effects may appear sooner
EvidenceStrong evidence
Affected systemsNorepinephrineSerotoninAcetylcholinenoo.affects.histamine

Contents

DETAILED OVERVIEW

What is Nortriptyline?

Nortriptyline is a prescription antidepressant of the older type known as tricyclic; it is the active breakdown product of the medicine amitriptyline and has been used since the 1960s. It is approved for depression, and outside its approval it is also prescribed for nerve pain, for preventing migraine and tension headache, and as a second-line aid for quitting smoking.

It mainly blocks the reuptake of noradrenaline, a chemical messenger in the brain; its side effects include dry mouth, constipation, drowsiness, weight gain and dizziness on standing up. It can also cause heart rhythm problems and can be dangerous in overdose, so it needs medical supervision. In people under 25 it can raise the risk of suicidal thoughts. It must not be given after a recent heart attack or together with MAO inhibitors. The evidence is strong: it is a well-studied medicine with long use.

Mechanism

NET-preferring reuptake inhibitor (TCA)

Half-life

~18-44 hours (about a day)

Legal status

Prescription antidepressant (Rx)

Receptor profile

  • Norepinephrine transporter (NET)Strong
  • Serotonin transporter (SERT)Moderate
  • Histamine H1 receptorModerate
  • Muscarinic acetylcholine receptorModerate
  • Alpha-1 adrenergic receptorModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Anticholinergic effects: dry mouth, constipation, blurred vision, urinary retention
  • Drowsiness, sedation and weight gain (H1 antagonism)
  • Orthostatic hypotension and dizziness (alpha-1 blockade)
  • Cardiac effects: tachycardia, arrhythmia, QT changes; dangerous in overdose
  • Sexual dysfunction, sweating, tremor
  • Increased risk of suicidal ideation in people under 25 (class-wide warning)

Contraindications · 5

  • Recent myocardial infarction, significant heart disease or conduction defects
  • Concurrent or recent (within 14 days) MAO inhibitor use
  • Known hypersensitivity to tricyclic antidepressants
  • Caution or avoidance in mania and bipolar disorder (can trigger a switch), narrow-angle glaucoma, urinary retention and seizure disorders
  • Pregnancy and breastfeeding: only if clearly indicated, under medical advice

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Nortriptyline is a long-established prescription medicine used mainly to treat more serious depression, but it is also used for chronic nerve-related pain and, off-label, to help prevent migraines and tension-type headaches. Its main advantage is that it tends to be better tolerated than older, similar medicines, causing less drowsiness and fewer dry-mouth type side effects. Under medical supervision, its dose can even be fine-tuned based on blood levels to balance effect and side effects.

Telegram

Have a question about Nortriptyline?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC19H21N
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.